Cellebrite DI (CLBT) Earnings Analysis

Cellebrite DI (CLBT) next reports earnings on 2026-08-13, consensus EPS 0.0739 USD. Last quarter (2026-05-14) it missed with EPS 0.04 USD vs 0.05377 USD est (-25.6%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E 48.55.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CLBT next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate0.0739 USD
Revenue estimate0.13B

CLBT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-140.04 USD0.05377 USD-25.6%Miss
2025-11-120.14 USD0.09449 USD+48.2%Beat
2025-08-140.12 USD0.1 USD+20%Beat
2025-02-130.1 USD0.1 USD0%Beat
2024-08-150.1 USD0.08 USD+25%Beat

Beat rate: 4/5 (80%) over reported quarters with consensus data.

CLBT valuation and analyst view

Trailing P/E48.55
Trailing EPS0.29157 USD
Price / book6.85
Dividend yield0.00%
Market cap3.56B
Analyst consensusBuy (8 buy / 0 hold / 0 sell)
Avg price target17.5 USD

Related research pages

Frequently asked questions

When is Cellebrite DI (CLBT)'s next earnings date?

Cellebrite DI is next scheduled to report on 2026-08-13, with a consensus EPS estimate of 0.0739 USD and revenue estimate of 0.13B.

Did CLBT beat earnings last quarter?

In its 2026-05-14 report, CLBT posted EPS of 0.04 USD versus a 0.05377 USD estimate — a miss of 25.6%.

What is CLBT's earnings track record?

Over the last 5 reported quarters with consensus data, CLBT beat estimates 4 times (80%).

What is CLBT's current P/E ratio and EPS?

CLBT trades at a trailing P/E of 48.55 on trailing EPS of 0.29157291154248155 USD.

What do analysts rate CLBT?

Analyst consensus is "Buy" across 8 ratings (0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 17.5 USD.